Jubilant Life gets US regulator approval for anti-inflammatory drug
Jubilant Life Sciences has a total of 84 ANDAs for oral solids filed in the US28-08-2017
28-08-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jubilant Stock Holding Pvt Ltd21-08-2017
Updates
Submission of copies of newspaper advertisements for 39th Annual General Meeting / Book Closure and e-Voting information08-08-2017
Fixes Book Closure for Dividend & AGM
Jubilant Life Sciences Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 19, 2017 to August 29, 2017 (both days inclusive) for the purpose of Payment of Dividend & 39th Annual General Meeting (AGM) of the Company to be held on August 29, 2017.08-08-2017
1. Annual General Meeting: - 39Th Annual General Meeting Of The Company Will Be Held On Tuesday, August 29, 2017. 2. Book Closure For Dividend From August 19, 2017 To August 29, 2017 (Both Days Inclusive)
We wish to inform you that the 39th Annual General Meeting ('AGM') of the Company will be held on Tuesday, August 29, 2017 at 11.30 a.m. at the Registered Office at Bhartiagram, Gajraula, District Amroha - 244 223, U.P. In this regard, we enclose a copy of the Notice of the 39th AGM, being despatched to the shareholders of the Company. In terms of Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure...05-08-2017
Jubilant Life gets USFDA nod for spasticity management drug
Drug firm Jubilant Life Sciences today said it has received final approval from the US health regulator for its Tizanidine Hydrochloride capsules used for management of spasticity. Jubilant...05-08-2017
Updates
Submission of copies of newspaper advertisements for Transfer of Equity Shares to Investor Education and Protection Fund04-08-2017